ADAMTS13 and congestive heart failure: A protective effect of increased activation of a clotting factor is contra-intuitive; rather, it seems more likely that patients with high VWF-A levels in this case are patients with a higher activity of the metalloprotease ADAMTS13, since ADAMTS13 activity is decreased in patients with congestive heart failure [16].